期刊文献+

雄激素受体亚型三阴性乳腺癌影像学诊断的研究进展

Research progress of imaging diagnosis in triple-negative breast cancer with androgen receptor expression
下载PDF
导出
摘要 乳腺癌(BC)是全球范围内最常见的女性恶性肿瘤,其中三阴性乳腺癌(TNBC)因为缺少有效治疗靶点而更加需要早诊断、早治疗,因此对不同分型的乳腺癌做出早期诊断及分型鉴别对于患者的预后有重要的意义。目前医学影像学检查技术发展迅速,通过结合多种影像学检查的特征性表现来早期鉴别不同分型的乳腺癌是一个新兴的领域,本文就影像学在雄激素受体亚型TNBC诊断方面的研究进展进行综述。 Breast cancer(BC)is the most common female malignant tumor in the world,among which triple-negative breast cancer(TNBC)needs early diagnosis and early treatment because of lack of effective treatment targets.Therefore,early diagnosis and differentiation of different types of breast cancer are of great significance for the prognosis of patients.At present,medical imaging technology is developing rapidly.It is a new field to distinguish different types of breast cancer early by combining various imaging features.This article reviews the research progress of imaging in the diagnosis of androgen receptor TNBC.
作者 叶兴宇 高磊 YE Xingyu;GAO Lei(Graduate School of Chengde Medical University,Chengde,Hebei 067000,China;Department of Ultrasound,Baoding NO.1 Central Hospital,Baoding,Hebei 071000,China)
出处 《影像研究与医学应用》 2024年第5期4-7,共4页 Journal of Imaging Research and Medical Applications
关键词 三阴性乳腺癌 雄激素受体 医学影像学 综述 Triple-negative breast cancer Androgen receptor Medical imaging Review
  • 相关文献

参考文献4

二级参考文献29

  • 1Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study [J]. JAMA, 2006, 295 (21): 2492-2502.
  • 2Harvey JM, Clark GM, Osborne CK, et al. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer [J]. J Clin Oncol, 1999,17:1474-1481.
  • 3Kaaks R, Rinaldi S, Key T J, et al. Postmenopausal serum androgens, oestrogens and breasf cancer risk: the European prospective investigation into cancer and nutrition [J]. Endocr Rerat Cancer, 2005,12 (4): 1071-1082.
  • 4Tworoger SS, Missmer SA, Eliassen AH, et al. The association of plasma DHEA and DHEA sulfate with breast cancer risk in predominantly premenopausal women [J]. Cancer Epidemiol Biomarkers Prev, 2006,15 (5):967-971.
  • 5Wong YC, Xie B. The role of androgens in mammary carcinogenesis [J]. Ital J Anat Embryol, 2001,106(2 Suppl 1):111-125.
  • 6Bryan RM, Mercer R J, Bennett RC, et al. Androgen receptors in breast cancer [J]. Cancer, 1984,54:2436-2440.
  • 7Agoff SN, Swanson PE, Linden H, et al. Androgen receptor expression in estrogen receptor-negative breast cancer. Immunohistochemical, clinical, and prognostic associations [J]. Am J Clin Pathol, 2003, 120 (5):725- 731.
  • 8Gonzalez LO, Cortel MD, Vazquez J, et al. Androgen receptor expresion in breast cancer: Relationship with clinicopathological characteristics of the tumors, prognosis, and expression of metalloprotenases and their inhibitors [J]. BMC Cancer, 2008,8:149.
  • 9Kuenen-Boumeester V, Van der Kwast TH, Claassen CC, et al. The clinical significance of androgen receptors in breast cancer and their relation to histological and cell biological parameters [J]. Eur J Cancer, 1996, 32A(9): 1560-1565.
  • 10Isola JJ. Immunohistochemical demonstration of androgen receptor in breast cancer and its relationship to other prognostic factors [J]. J Pathal, 1993,170(1 ):31-35.

共引文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部